Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Neuroone Medical Technologies (NMTC) Long-Term Debt Issuances (2016 - 2020)

Neuroone Medical Technologies (NMTC) has disclosed Long-Term Debt Issuances for 6 consecutive years, with $5.0 million as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Long-Term Debt Issuances changed N/A year-over-year to $5.0 million, compared with a TTM value of $142427.0 through Dec 2020, changed N/A, and an annual FY2020 reading of $8.4 million, changed N/A over the prior year.
  • Long-Term Debt Issuances was $5.0 million for Q4 2020 at Neuroone Medical Technologies, up from -$534201.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $5.0 million in Q4 2020 and bottomed at -$4.5 million in Q2 2017.
  • Average Long-Term Debt Issuances over 3 years is $23361.9, with a median of $8210.0 recorded in 2016.
  • The sharpest move saw Long-Term Debt Issuances skyrocketed 243.3% in 2016, then plummeted 55103.64% in 2017.
  • Year by year, Long-Term Debt Issuances stood at $21106.0 in 2016, then plummeted by 2631.04% to -$534201.0 in 2017, then surged by 1035.98% to $5.0 million in 2020.
  • Business Quant data shows Long-Term Debt Issuances for NMTC at $5.0 million in Q4 2020, -$534201.0 in Q3 2017, and -$4.5 million in Q2 2017.